Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

David Rogers

Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

November 15, 2024
Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.
Read Transcript

‍It’s one of the best known brands in the world but Estee Lauder has been pummeled.

For Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

In her Sohn Hearts & Minds Conference debut, Ms Wright says Estee Lauder is set to regain its premium share market valuation amid emerging “mega-trends” in the cosmetics industry.

Estee Lauder shares rose five fold in the five-years to the start of 2022. Its skin care and travel retail divisions were driving-double digit organic sales growth and strong margin expansion. The company had an enviable track record and brand and still does.

Despite the initial uncertainty of Covid, e-commerce took off and the removal of travel restrictions in the US and Europe had Estee management primed for China’s reopening.

“But then, just like that, the party stopped,” Wright said.

“China didn’t reopen, Asia slowed, and US and European ‘revenge spend’ abated.

“Estee found itself with too much product in the wrong place at the wrong time.”

At that point the company suffered from an excess of inventory built up to meet demand during the pandemic, losing about 80 percent of its value over the next two years.

At current levels around $US64.83 versus a record high of $US374.20 in early 2022, the share price is well below the levels where Northcape began buying in 2019.

“But I’m here to tell you that the worst is over,” Wright said.

The company now has a restructuring plan to boost its profit by $US1.4bn by 2026.

That’s 80 per cent of the profit that the company delivered last year.

“Now we also have a catalyst after their poor performance in recent years,” Wright said.

“We have a whole new senior management team ready to take estate to the next level.

“Put those earnings on Estee’s historic PE multiple, and you get a share price return that is more than double.

“This is one of those rare times to buy a quality company at an attractive price.”

With a $25bn market capitalisation, the US-listed cosmetics company doesn’t just own the Estee Lauder brand. It has over 20 well known global premium beauty brands.

It’s a big part of why its share price has historically commanded a PE premium of 1.7 times, which is what Northcape paid for the shares when it launched its global equity fund in 2019.

“It’s a great example of the type of high quality business I like to invest in,” Wright said.

“It meets all of North Cape’s quality principles, meaning it can sustainably generate returns well above its cost of capital reinvest and grow and hence to live on long term share price out performance.”

Estee is the third biggest cosmetics maker globally, with huge economies of scale in research and development, manufacturing and marketing. It also dominates in “prestige beauty”, where there’s less competition and brand recognition and luxury reputation are “really hard to replicate”.

It’s also in a growth industry, one where Estee has a long track record of outperforming by over 50 per cent, with mid-single plus organic sales growth for over the past 30 years.

Ongoing China stimulus measures could provide a boost, as while cosmetics are thought to be a discretionary spending item, they have actually historically behaved more Like a staple.

Former CEO Leonard Lauder coined it the “lipstick effect”, after observing the purchases of affordable luxuries like lipstick, actually tended to go up as economic growth rates fell.

“So whilst I might be worried about a recession (in China) in coming years, I’m a whole lot less worried about its impact on Estee,” Wright added.

But she also sees “mega trends” driving long-term growth for Estee Lauder.

Firstly, spending per capita has room to grow because consumers in emerging markets countries are spending only a fraction on beauty products compared to the US, Europe and Japan.

Secondly, consumers tend to spend more on beauty products as they age. For countries like China where population growth has stopped, the average age of people is getting older.

Third, additional growth categories are opening up with the help of innovation into areas like home fragrances. Finally, men are increasingly starting to use cosmetics.

“Together, these factors should help return Estee to its mid- to-high single digit organic growth trajectory, and importantly, I think they can do a whole lot better than this,” Wright said.

“After the recent years of declines, Estee can grow again.”

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

‍It’s one of the best known brands in the world but Estee Lauder has been pummeled.

For Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

In her Sohn Hearts & Minds Conference debut, Ms Wright says Estee Lauder is set to regain its premium share market valuation amid emerging “mega-trends” in the cosmetics industry.

Estee Lauder shares rose five fold in the five-years to the start of 2022. Its skin care and travel retail divisions were driving-double digit organic sales growth and strong margin expansion. The company had an enviable track record and brand and still does.

Despite the initial uncertainty of Covid, e-commerce took off and the removal of travel restrictions in the US and Europe had Estee management primed for China’s reopening.

“But then, just like that, the party stopped,” Wright said.

“China didn’t reopen, Asia slowed, and US and European ‘revenge spend’ abated.

“Estee found itself with too much product in the wrong place at the wrong time.”

At that point the company suffered from an excess of inventory built up to meet demand during the pandemic, losing about 80 percent of its value over the next two years.

At current levels around $US64.83 versus a record high of $US374.20 in early 2022, the share price is well below the levels where Northcape began buying in 2019.

“But I’m here to tell you that the worst is over,” Wright said.

The company now has a restructuring plan to boost its profit by $US1.4bn by 2026.

That’s 80 per cent of the profit that the company delivered last year.

“Now we also have a catalyst after their poor performance in recent years,” Wright said.

“We have a whole new senior management team ready to take estate to the next level.

“Put those earnings on Estee’s historic PE multiple, and you get a share price return that is more than double.

“This is one of those rare times to buy a quality company at an attractive price.”

With a $25bn market capitalisation, the US-listed cosmetics company doesn’t just own the Estee Lauder brand. It has over 20 well known global premium beauty brands.

It’s a big part of why its share price has historically commanded a PE premium of 1.7 times, which is what Northcape paid for the shares when it launched its global equity fund in 2019.

“It’s a great example of the type of high quality business I like to invest in,” Wright said.

“It meets all of North Cape’s quality principles, meaning it can sustainably generate returns well above its cost of capital reinvest and grow and hence to live on long term share price out performance.”

Estee is the third biggest cosmetics maker globally, with huge economies of scale in research and development, manufacturing and marketing. It also dominates in “prestige beauty”, where there’s less competition and brand recognition and luxury reputation are “really hard to replicate”.

It’s also in a growth industry, one where Estee has a long track record of outperforming by over 50 per cent, with mid-single plus organic sales growth for over the past 30 years.

Ongoing China stimulus measures could provide a boost, as while cosmetics are thought to be a discretionary spending item, they have actually historically behaved more Like a staple.

Former CEO Leonard Lauder coined it the “lipstick effect”, after observing the purchases of affordable luxuries like lipstick, actually tended to go up as economic growth rates fell.

“So whilst I might be worried about a recession (in China) in coming years, I’m a whole lot less worried about its impact on Estee,” Wright added.

But she also sees “mega trends” driving long-term growth for Estee Lauder.

Firstly, spending per capita has room to grow because consumers in emerging markets countries are spending only a fraction on beauty products compared to the US, Europe and Japan.

Secondly, consumers tend to spend more on beauty products as they age. For countries like China where population growth has stopped, the average age of people is getting older.

Third, additional growth categories are opening up with the help of innovation into areas like home fragrances. Finally, men are increasingly starting to use cosmetics.

“Together, these factors should help return Estee to its mid- to-high single digit organic growth trajectory, and importantly, I think they can do a whole lot better than this,” Wright said.

“After the recent years of declines, Estee can grow again.”

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Nov 15, 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
October 8, 2024

Sumit Gautam - Why AI won't deliver in 2025 | Scalar Gauge

Sumit Gautam is the Founder of Scalar Gauge and speaks with Equity Mates ahead of his appearance at the Sohn Hearts & Minds conference.

Read More
September 30, 2024

Missed out on Nvidia and Ozempic? This fundie says it’s never too late

Northcape Capital’s Fleur Wright is still kicking herself for not owning market darlings Nvidia and Novo Nordisk, the maker of the weight loss wonder drug Ozempic, before shares of those companies rocketed in 2023.

Read More
September 23, 2024

Scalar Gauge Fund founder Sumit Gautam cautious about over-hyped AI

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype.

Read More
September 9, 2024

The Wellcome Trust’s Nick Moakes made a 100-year bet. It’s paying off

Chief Investment Officer, Nick Moakes raised almost $3 billion at ultra-low rates. Sometimes the long view can be the most profitable.

Read More
Wellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven Pocock
September 5, 2024

Honesty the only policy that matters, says Wellcome Trust’s Nicholas Moakes

The chief investment officer of the London-based $71bn Wellcome Trust, Nick Moakes, has a simple rule for the trust’s investment team: “Never invest with anyone who is or has been or should have been in prison.”

Read More
September 5, 2024

Why Howard Marks says you’re making a big mistake

Howard Marks says investors must ignore manic depressive markets and focus on the bigger picture. Rates will be higher for longer and that will bring pain – and opportunity.

Read More
July 21, 2024

Investors ‘comfortable’ about a Trump presidency, despite volatility

Economists and market experts say the outcome of the US presidential election has been largely priced in by investors as softening inflation helps to buoy sharemarkets both globally and locally.

Read More
February 15, 2024

Hedge fund Munro says Nvidia, Microsoft have more to run

Kieran Moore is portfolio manager of Munro Partners Global Growth Fund. The Melbourne-based hedge fund oversees $4.3 billion in assets.

Read More
January 24, 2024

How To Master The Art Of Winning The Room

Jonathan Pease, the creative director behind the Sohn Hearts & Minds Conference and author of the book, Winning the Room, recently sat down for a chat with Mark Bouris on Straight Talk.

Read More
November 19, 2023

Equity Mates review the stocks pitched at the Sohn Hearts & Minds Conference

Bryce and Ren of Equity Mates attended the Sohn Hearts & Minds Conference and reviewed the stocks pitched by our new 2023 Conference Fund Managers.

Read More
Ark Invest CEO Cathie Wood remains as big-picture as ever. Picture: David RoweArk Invest CEO Cathie Wood remains as big-picture as ever. Picture: David RoweArk Invest CEO Cathie Wood remains as big-picture as ever. Picture: David RoweArk Invest CEO Cathie Wood remains as big-picture as ever. Picture: David Rowe
November 17, 2023

‘I Know It Sounds Crazy’: Cathie Wood’s Next Big Idea

Speaking from Ark’s headquarters in Florida ahead of her appearance at the Sohn Hearts & Minds Conference on Friday, Wood says she believes disinflation is now just around the corner in the US.

Read More
ARK Invest founder Cathie Wood: It does appear that the SEC here in the United States is likely to approve a spot bitcoin ETF within the next few months.ARK Invest founder Cathie Wood: It does appear that the SEC here in the United States is likely to approve a spot bitcoin ETF within the next few months.ARK Invest founder Cathie Wood: It does appear that the SEC here in the United States is likely to approve a spot bitcoin ETF within the next few months.ARK Invest founder Cathie Wood: It does appear that the SEC here in the United States is likely to approve a spot bitcoin ETF within the next few months.
November 17, 2023

ARK Founder Wood Backs Bitcoin, Banking On Spot ETF Approval

Tech investment guru Cathie Wood is still a big believer in bitcoin, so it was fitting that she chose Grayscale Bitcoin Trust as her stock pick for the 2023 Sohn Hearts & Minds Investment Leaders Conference.

Read More
IFM Investors small cap specialist Rikki Bannan addresses the Sohn Hearts & Minds Investment Leaders Conference at Sydney Opera House. Picture: Renee NowytargerIFM Investors small cap specialist Rikki Bannan addresses the Sohn Hearts & Minds Investment Leaders Conference at Sydney Opera House. Picture: Renee NowytargerIFM Investors small cap specialist Rikki Bannan addresses the Sohn Hearts & Minds Investment Leaders Conference at Sydney Opera House. Picture: Renee NowytargerIFM Investors small cap specialist Rikki Bannan addresses the Sohn Hearts & Minds Investment Leaders Conference at Sydney Opera House. Picture: Renee Nowytarger
November 17, 2023

Hot Stocks To Ride The Next Healthcare Trends

Healthcare stocks – from sleep apnoea giant ResMed, to cancer diagnostic biotech Telix Pharmaceuticals – were recommended at the Sohn Hearts & Minds Investment Leaders Conference on Friday.

Read More
November 17, 2023

How Daniel Loeb, The Real Bobby Axelrod, Made His Wall Street Billions

When Damian Lewis, the actor who plays the ruthless hedge fund boss in the drama series Billions was looking for inspiration, he sat down with Daniel Loeb.

Read More
November 17, 2023

The 12 Hottest Stock Tips From This Year’s Sohn Experts

It might be time to look beyond big names. That was the message from top fund managers, company founders and super funds at the Sohn Hearts & Minds.

Read More